Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 417,195 | 360,540 | 329,738 | 259,489 | 541,158 |
| Marketable Securities | N/A | 108,167 | 124,683 | 140,014 | N/A |
| Receivables | 123,022 | 136,346 | 141,825 | 140,410 | 157,046 |
| Inventories | 37,642 | 37,583 | 39,668 | 51,613 | 44,233 |
| Other current assets | 10,798 | 10,025 | 8,940 | 10,350 | 5,613 |
| TOTAL | $602,323 | $673,039 | $660,013 | $617,261 | $767,479 |
| Non-Current Assets | |||||
| PPE Net | 7,813 | 8,505 | 9,130 | 9,670 | 10,108 |
| Intangibles | 0 | 3,563 | 3,563 | 3,563 | 3,563 |
| Other Non-Current Assets | 69,198 | 56,619 | 66,836 | 62,809 | 60,499 |
| TOTAL | $77,011 | $68,687 | $79,529 | $76,042 | $74,170 |
| Total Assets | $679,334 | $741,726 | $739,542 | $693,303 | $841,649 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 125,278 | 119,011 | 106,987 | N/A |
| Accounts payable and accrued liabilities | 16,159 | 45,707 | 14,568 | 15,482 | 15,201 |
| Accrued Expenses | 149,168 | 149,363 | 153,473 | 135,132 | 130,452 |
| TOTAL | $165,327 | $320,348 | $287,052 | $257,601 | $145,653 |
| Non-Current Liabilities | |||||
| Long Term Debt | 75,513 | 57,924 | 63,420 | 74,696 | 74,481 |
| Other Non-Current Liabilities | 340,768 | 232,694 | 232,850 | 233,335 | 340,541 |
| TOTAL | $416,281 | $290,618 | $296,270 | $308,031 | $415,022 |
| Total Liabilities | $581,608 | $610,966 | $583,322 | $565,632 | $560,675 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,275 | 76,785 | 76,480 | 75,752 | 72,794 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -1,049,854 | -1,004,129 | -965,601 | -935,701 | -762,754 |
| Other shareholders' equity | -270 | -273 | -267 | -307 | -270 |
| TOTAL | $97,726 | $130,760 | $156,220 | $127,671 | $280,974 |
| Total Liabilities And Equity | $679,334 | $741,726 | $739,542 | $693,303 | $841,649 |